Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Estrogen receptor alpha (ERα) is a nuclear hormone receptor and transcription factor that mediates cellular responses to estrogens. It plays critical roles in reproductive system development and function, bone density regulation, metabolic homeostasis, cardiovascular protection, and modulation of inflammatory processes. ERα dysregulation is implicated in various diseases, including breast cancer, ovarian cancer, prostate cancer, metabolic disorders, and cardiovascular disease. It is a key therapeutic target, particularly in ER-positive breast cancer.
Ligand-dependent nuclear transcription factor; upon binding estrogen ligands, ERα dimerizes and translocates to the nucleus where it binds EREs on target genes or interacts with other transcription factors. Also mediates rapid non-genomic signaling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Estrogen Receptor Alpha (ERα).